Invests from product inception through global scaling with $500K–$40M checks, exclusively in interactive entertainment, delivering hands-on support from former Riot and Activision Blizzard leaders across major gaming hubs. With a disciplined investment approach, the team drives value for both founders and investors.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Operates as a follow-on, game-developer–only investor building a curated global peer community that funds shared industry data, expert sessions and retreats; roughly one-third of invested companies are female-founded. With a disciplined investment approach, the team drives value for both founders and investors.
Pre-seed investor writing the first institutional check, operating a Venice entrepreneurial campus where founders and investors co-work, with Hollywood-connected mentors providing direct access to celebrity, media and brand networks. The firm continues to build its presence across the venture capital landscape.
Operator-led, gaming-first investor with crypto-native strategies and specialized funds, the most active global lead investor leveraging esports founder experience and token-focused expertise for founders. The firm continues to build its presence across the venture capital landscape.
Early-phase investor in deep-tech—AI, digital security, quantum, robotics, space tech, synthetic biology—with rare bioengineering focus and technically deep partners who engage with complex product and R&D. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
